Lido Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,212
Closed -$254K 1908
2025
Q2
$254K Buy
10,212
+170
+2% +$4.79K ﹤0.01% 1414
2025
Q1
$311K Hold
10,042
﹤0.01% 1201
2024
Q4
$317K Buy
10,042
+42
+0.4% +$2K ﹤0.01% 1188
2024
Q3
$579K Buy
+10,000
New +$491K ﹤0.01% 909

Other funds holding ASTH

Lido Advisors's ASTH Position: Q3 2025 in Review

Lido Advisors sold out of Astrana Health (ASTH) in Q3 2025, closing a stake of 10,212 shares — an estimated $254K sold.

Lido Advisors first reported a position in ASTH in Q3 2024 and held it in 4 quarters. The position peaked at $579K in Q3 2024. 188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Lido Advisors reported no remaining Astrana Health position as of Q3 2025 after selling out during the quarter.
  • Lido Advisors sold 10,212 Astrana Health shares in Q3 2025, an estimated $254K.
  • Lido Advisors first reported a position in Astrana Health in Q3 2024 and held it in 4 quarters.
  • Lido Advisors's Astrana Health position peaked at $579K in Q3 2024.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Lido Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.